Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D E Casey

Showing results (31-40 of 123) with videos related to

Pageof 13
Sort By:
Psychopharmacology|October 1, 1995
The effects of D1 (NNC 22-0215) and D2 (haloperidol) antagonists in a chronic double-blind placebo controlled trial in cebus monkeysD E Casey
Neurology|July 1, 1980
Pharmacology of blepharospasm-oromandibular dystonia syndromeD E Casey
The Journal of Clinical Psychiatry|April 16, 1998
Effects of clozapine therapy in schizophrenic individuals at risk for tardive dyskinesiaD E Casey
Psychopharmacology|April 11, 1979
Mood alterations during deanol therapyD E Casey
The New England Journal of Medicine|August 14, 1975
Letter: Deanol for tardive dyskinesiaD E Casey
The Journal of Clinical Psychiatry|May 31, 2001
Clinical trial design issues in schizophrenic researchD E Casey
The New England Journal of Medicine|March 2, 1978
Amantadine intoxication reversed by physostigmineD E Casey
Acta Psychiatrica Scandinavica. Supplementum|January 1, 1994
Motor and mental aspects of acute extrapyramidal syndromesD E Casey
Diseases of the Nervous System|December 1, 1977
Deanol in the management of involuntary movement disorders: a reviewD E Casey
Psychopharmacology. Supplementum|January 1, 1985
Tardive dyskinesia: nondopaminergic treatment approachesD E Casey
Pageof 13

Showing results (31-40 of 123) with videos related to

Sort By:
Pageof 13
Psychopharmacology|October 1, 1995
The effects of D1 (NNC 22-0215) and D2 (haloperidol) antagonists in a chronic double-blind placebo controlled trial in cebus monkeysD E Casey
Neurology|July 1, 1980
Pharmacology of blepharospasm-oromandibular dystonia syndromeD E Casey
The Journal of Clinical Psychiatry|April 16, 1998
Effects of clozapine therapy in schizophrenic individuals at risk for tardive dyskinesiaD E Casey
Psychopharmacology|April 11, 1979
Mood alterations during deanol therapyD E Casey
The New England Journal of Medicine|August 14, 1975
Letter: Deanol for tardive dyskinesiaD E Casey
The Journal of Clinical Psychiatry|May 31, 2001
Clinical trial design issues in schizophrenic researchD E Casey
The New England Journal of Medicine|March 2, 1978
Amantadine intoxication reversed by physostigmineD E Casey
Acta Psychiatrica Scandinavica. Supplementum|January 1, 1994
Motor and mental aspects of acute extrapyramidal syndromesD E Casey
Diseases of the Nervous System|December 1, 1977
Deanol in the management of involuntary movement disorders: a reviewD E Casey
Psychopharmacology. Supplementum|January 1, 1985
Tardive dyskinesia: nondopaminergic treatment approachesD E Casey
Pageof 13